Volker Sandig

Volker Sandig is a seasoned professional in the field of molecular biology and biomedicine, currently serving as Chief Scientific Officer at ProBioGen AG since March 2000, with a focus on patents and patent applications, including EP Nr. 18 181 748. Prior experience includes roles as Vice President of Cell and Vector Biology at Merck & Co. Inc. from 1997 to 2000, and Senior Scientist and Group Leader at Hepavec from 1996 to 1997. Volker Sandig also held the position of Group Leader at the Max Planck Society from 1993 to 1996 and was a Postdoctoral Researcher during this time. Educational credentials include a Ph.D. in Molecular Biology from Humboldt-Universität zu Berlin (1990-1993) and an MD in Medicobiology from the 2nd Medical Institute Pirogov in Moscow (1981-1987).